インフォショップ ホームへ 株式会社グローバルインフォメーション
サイトマップ
その他のカテゴリ

商品カタログ

医療/バイオの調査資料販 MEDINFO.JP

先端癌治療特集
BioSeeker Group - 先端癌治療特集ページ 用途別にデータベース、調査資料等をご紹介いたします
BioSeeker Group社
発行

World Vaccine Congress Australia 2008 公式サイト

Drug Discovery & Development of Innovative Therapeutics India 公式サイト

Discovery2Diagnostics 公式サイト

Discovery On Target 公式サイト

Drug Delivery Technology Asia 2008 公式サイト

Post-Approval Drug Safety Strategies 公式サイト

Drug Discovery & Development of Innovative Therapeutics Japan 2009 公式サイト
English Korean Chinese
【 英文市場調査報告書 】

中国における創傷治療市場

Wound Treatments in China

商品コード : 58471 Euromonitor International
出版日 : 2008/07
発行 : Euromonitor International
電話でのお問い合わせ
価格情報
概要 原文目次
※この商品は英文にてご提供いたします。

Abstract

  • Euromonitor International' s Wound Treatments in China report offers a comprehensive guide to the size and shape of the market at a national level.
  • It provides the latest retail sales data (2002-2007), allowing you to identify the sectors driving growth.
  • It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues.
  • Forecasts to 2012 illustrate how the market is set to change.
  • Product coverage: sticking plasters, other wound treatments
  • Data coverage: market sizes (historic and forecasts), company shares and brand shares
  • Why buy this report?
    • Get a detailed picture of the wound treatments industry
    • Identify growth sectors and factors driving change
    • Understand the competitive environment, the market' s major players and leading brands
    • Use five-year forecasts to assess how the market is predicted to develop
  • Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems.
  • With offices in London, Chicago, Singapore, Shanghai, Vilniuis and Dubai and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Table of Contents

  • List of Contents and Tables
  • OTC HEALTHCARE IN CHINA
  • Executive Summary
  • Rising Incomes and Lifestyle Changes Drive the Market
  • Chinese OTC Healthcare Market Becomes More Consolidated
  • Amway Consolidates Its Leading Position
  • New Channels Development Could Not Change the Domination of Chemists
  • Strong Growth Is Expected in the Forecast Period
  • Key Trends and Developments
  • Rising Income and Constant Price Push OTC Sales
  • Demographic and Lifestyle Changes Stimulate Demand for OTC Products
  • Self-medication Drives the Market
  • Market Concentration Appears To Be More Significant
  • Chemists Remain the Main Sales Channel
  • Territory Key Trends and Developments
  • East China
  • Mid China
  • North and Northeast China
  • Northwest China
  • South China
  • Southwest China
  • Market Indicators
    • Table 1 Consumer Expenditure on Health Goods and Medical Services 2002-2007
    • Table 2 Life Expectancy at Birth 2002-2007
  • Market Data
    • Table 3 Sales of OTC Healthcare by Sector: Value 2002-2007
    • Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2002-2007
    • Table 5 Sales of OTC Healthcare by Region: Value 2002-2007
    • Table 6 Sales of OTC Healthcare by Region: % Value Growth 2002-2007
    • Table 7 OTC Healthcare Company Shares by Value 2003-2007
    • Table 8 OTC Healthcare Brand Shares by Value 2004-2007
    • Table 9 Sales of OTC Healthcare by Distribution Format: % Analysis 2002-2007
    • Table 10 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2007
    • Table 11 Forecast Sales of OTC Healthcare by Sector: Value 2007-2012
    • Table 12 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2007-2012
    • Table 13 Forecast Sales of OTC Healthcare by Region: Value 2007-2012
    • Table 14 Forecast Sales of OTC Healthcare by Region: % Value Growth 2007-2012
  • Appendix
  • OTC Registration and Classification
  • Vitamins and Dietary Supplements Registration and Classification
  • Generics
  • Switches
    • Summary 1 OTC Healthcare Switches 2005-2007
  • Definitions
  • Sources
    • Summary 2 Research Sources
  • LOCAL COMPANY PROFILES - CHINA
  • Amway (china) Co Ltd
  • Strategic Direction
  • Key Facts
    • Summary 3 Amway (China) Co Ltd: Key Facts
  • Company Background
  • Production
  • Competitive Positioning
    • Summary 4 Amway (China) Co Ltd: Competitive Position 2007
  • Bristol-Myers Squibb (shanghai) Trading Co Ltd
  • Strategic Direction
  • Key Facts
    • Summary 5 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Key Facts
  • Company Background
  • Production
    • Summary 6 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Production Statistics 2007
  • Competitive Positioning
    • Summary 7 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Competitive Position 2007
  • Guangzhou Pan Gao Shou Pharm Co Ltd
  • Strategic Direction
  • Key Facts
    • Summary 8 Guangzhou Pan Gao Shou Pharm Co Ltd: Key Facts
  • Company Background
  • Production
    • Summary 9 Guangzhou Pan Gao Shou Pharm Co Ltd: Production Statistics 2007
  • Competitive Positioning
    • Summary 10 Guangzhou Pan Gao Shou Pharm Co Ltd: Competitive Position 2007
  • Harbin Pharmaceutical Group Sanjing Pharm Co Ltd
  • Strategic Direction
  • Key Facts
    • Summary 11 Harbin Pharmaceutical Group Sanjing Pharm Co Ltd: Key Facts
  • Company Background
  • Production
  • Competitive Positioning
    • Summary 12 Harbin Pharmaceutical Group Sanjing Pharm Co Ltd: Competitive Position 2007
  • Kunming Dianhong Pharm Co Ltd
  • Strategic Direction
  • Key Facts
    • Summary 13 Kunming Dianhong Pharm Co Ltd: Key Facts
  • Company Background
  • Production
  • Competitive Positioning
    • Summary 14 Kunming Dianhong Pharm Co Ltd: Competitive Position 2007
  • Shanghai Jiao Da Onlly Co Ltd
  • Strategic Direction
  • Key Facts
    • Summary 15 Shanghai Jiao Da Onlly Co Ltd: Key Facts
  • Company Background
  • Production
  • Competitive Positioning
    • Summary 16 Shanghai Jiao Da Onlly Co Ltd: Competitive Position 2007
  • Tianjin Tianshi Biological Development Co Ltd
  • Strategic Direction
    • Summary 17 Tianjin Tianshi Biological Development Co Ltd: Key Facts
  • Company Background
  • Production
  • Competitive Positioning
    • Summary 18 Tianjin Tianshi Biological Development Co Ltd: Competitive Position 2007
  • Tibet Linzhi Qizheng Tibetan Medicine Fty
  • Strategic Direction
  • Key Facts
    • Summary 19 Tibet Linzhi Qizheng Tibetan Medicine Fty: Key Facts
  • Company Background
  • Production
    • Summary 20 Tibet Linzhi Qizheng Tibetan Medicine Fty: Production Statistics 2007
  • Competitive Positioning
    • Summary 21 Tibet Linzhi Qizheng Tibetan Medicine Fty: Competitive Position 2007
  • Wyeth Pharmaceutical Co Ltd
  • Strategic Direction
  • Key Facts
    • Summary 22 Wyeth Pharmaceutical Co Ltd: Key Facts
  • Company Background
  • Production
    • Summary 23 Wyeth Pharmaceutical Co Ltd: Production Statistics 2007
  • Competitive Positioning
    • Summary 24 Wyeth Pharmaceutical Co Ltd: Competitive Position 2007
  • Xian Janssen Pharmaceutical Ltd
  • Strategic Direction
  • Key Facts
    • Summary 25 Xian Janssen Pharmaceutical Ltd: Key Facts
  • Company Background
  • Production
  • Competitive Positioning
    • Summary 26 Xian Janssen Pharmaceutical Ltd: Competitive Position 2007
  • WOUND TREATMENTS IN CHINA
  • Overview
  • Sector Data
    • Table 15 Sales of Wound Treatments by Subsector: Value 2002-2007
    • Table 16 Sales of Wound Treatments by Subsector: % Value Growth 2002-2007
    • Table 17 Wound Treatments Company Shares by Value 2003-2007
    • Table 18 Wound Treatments Brand Shares by Value 2004-2007
    • Table 19 Forecast Sales of Wound Treatments by Subsector: Value 2007-2012
    • Table 20 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2007-2012
  • Wound treatments China
概要 原文目次
※この商品は英文にてご提供いたします。
【 英文市場調査報告書 】
中国における創傷治療市場
Wound Treatments in China
出版日 : 2008/07
電話でのお問い合わせ
この商品について問い合わせる
この商品のサンプル(抜粋)を依頼する
価格

※ドル建て価格の商品のお支払いは、銀行レート (TTS: 102.63) 換算による円建てのご請求書にて承ります。

US $ 900 換算 -> ¥ 92,367 (税抜) PDF by E-mail (Single User License)
商品コード : 58471